Ischemic preconditioning attenuates morphological and biochemical changes in hepatic ischemia/reperfusion in rats

Pathobiology

Volumn 77, Issue 3, 2010, Pages 136-146

  Jin, Li Ming ^a   Liu, Yuan Xing ^a   Zhou, Lin ^a   Xie, Hai Yang ^a   Feng, Xiao Wen ^a   Li, Hui ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Ischemia reperfusion injury; Ischemic preconditioning; Leukocyte; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; HYALURONIC ACID; MALONALDEHYDE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ISCHEMIC PRECONDITIONING; LIVER CELL; LIVER ISCHEMIA; LIVER NECROSIS; LIVER PROTECTION; LIVER SINUSOID; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CASPASE 3; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HEPATOCYTES; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; NECROSIS; NEUTROPHIL INFILTRATION; PEROXIDASE; RATS; RATS, WISTAR; REPERFUSION INJURY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WARM ISCHEMIA;

EID: 77953190212     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000292647     Document Type: Article

References (48)

1. Clavien PA, Selzner M, Rudiger HA, et al: A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-852.
2. Liu YX, Jin LM, Zhou L, et al: Mycophenolate mofetil attenuates liver ischemia/reperfusion injury in rats. Transpl Int 2009; 22: 747-756.
3. Clavien PA, Petrowsky H, DeOliveira ML, et al: Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-1559.
4. Yadav SS, Sindram D, Perry DK, et al: Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999;30: 1223-1231.
5. Breitenstein S, Apestegui C, Petrowsky H, et al: 'State of the art' in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J Surg 2009; 33:797-803.
6. Banga NR, Homer-Vanniasinkam S, Graham A, et al: Ischaemic preconditioning in transplantation and major resection of the liver. Br J Surg 2005; 92:528-538.
7. DeOliveira ML, Graf R, Clavien PA: Ischemic preconditioning: promises from the laboratory to patients - sustained or disillusioned? Am J Transplant 2008;8: 489-491.
8. Kataoka M, Shimizu H, Mitsuhashi N, et al: Effect of cold-ischemia time on C-X-C chemokine expression and neutrophil accumulation in the graft liver after orthotopic liver transplantation in rats. Transplantation 2002;73:1730-1735.
9. Montalvo-Jave EE, Pina E, Montalvo-Arenas C, et al: Role of ischemic preconditioning in liver surgery and hepatic transplantation. J Gastrointest Surg 2009;13:2074-2083.
10. Zahler S, Kupatt C, Becker BF: Endothelial preconditioning by transient oxidative stress reduces inflammatory responses of cultured endothelial cells to TNF-alpha. FASEB J 2000;14:555-564.
11. Amador A, Grande L, Marti J, et al: Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 2007;7:2180-2189. (Pubitemid 47247061)
12. Ambros JT, Herrero-Fresneda I, Borau OG, et al: Ischemic preconditioning in solid organ transplantation: from experimental to clinics. Transpl Int 2007;20:219-229.
13. Arkadopoulos N, Kostopanagiotou G, Theodoraki K, et al: Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial. World J Surg 2009;33:1909-1915.
14. Franchello A, Gilbo N, David E, et al: Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/ reperfusion injury (IRI). Am J Transplant 2009; 9:1629-1639.
15. Suzuki S, Inaba K, Konno H: Ischemic preconditioning in hepatic ischemia and reperfusion. Curr Opin Organ Transplant 2008; 13:142-147.
16. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136.
17. Gumina RJ, Gross GJ: If ischemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? Comparison with NHE inhibition. J Thromb Thrombolysis 1999; 8:39-44.
18. Lloris-Carsi JM, Cejalvo D, Toledo-Pereyra LH, et al: Preconditioning: effect upon lesion modulation in warm liver ischemia. Transplant Proc 1993;25:3303-3304.
19. Matsumoto T, O'Malley K, Efron PA, et al: Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning. Surgery 2006;140:793-802.
20. Ofluoglu E, Kerem M, Pasaoglu H, et al: Delayed energy protection of ischemic preconditioning on hepatic ischemia/reperfusion injury in rats. Eur Surg Res 2006;38:114-121.
21. Clavien PA, Yadav S, Sindram D, et al: Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000;232: 155-162.
22. Caldwell-Kenkel JC, Currin RT, Tanaka Y, et al: Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology 1989;10:292-299.
23. Miyagawa Y, Imamura H, Soeda J, et al: Fate of hepatocyte and sinusoidal lining cell function and kinetics after extended cold preservation and transplantation of the rat liver. Liver Transpl 2002;8: 370-381.
24. Kohli V, Selzner M, Madden JF, et al: Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999;67: 1099-1105.
25. Klintman D, Li X, Santen S, et al: p38 mitogen- activated protein kinase-dependent chemokine production, leukocyte recruitment, and hepatocellular apoptosis in endotoxemic liver injury. Ann Surg 2005;242: 830-839.
26. Vinten-Johansen J, Zhao ZQ, Jiang R, et al: Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury. J Appl Physiol 2007;103:1441-1448.
27. Teoh NC, Farrell GC: Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003;18:891-902.
28. Gao W, Bentley RC, Madden JF, et al: Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998;27: 1652-1660.
29. Arai M, Thurman RG, Lemasters JJ: Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 2001;7:292-299.
30. Arai M, Peng XX, Currin RT, et al: Protection of sinusoidal endothelial cells against storage/reperfusion injury by prostaglandin E 2 derived from Kupffer cells. Transplantation 1999; 68:440-445.
31. Quireze C, Montero EF, Leitao RM, et al: Ischemic preconditioning prevents apoptotic cell death and necrosis in early and intermediate phases of liver ischemia-reperfusion injury in rats. J Invest Surg 2006;19:229-236.
32. Imamura H, Kokudo N, Sugawara Y, et al: Pringle's maneuver and selective inflow occlusion in living donor liver hepatectomy. Liver Transpl 2004;10:771-778.
33. Shimoda M, Iwasaki Y, Sawada T, et al: Protective effect of ischemic preconditioning against liver injury after major hepatectomy using the intermittent Pringle maneuver in swine. Pathobiology 2007;74:42-49.
34. Tejima K, Arai M, Ikeda H, et al: Ischemic preconditioning protects hepatocytes via reactive oxygen species derived from Kupffer cells in rats. Gastroenterology 2004; 127: 1488-1496.
35. Cursio R, Gugenheim J, Ricci JE, et al: A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 1999;13: 253-261.
36. Arab HA, Sasani F, Rafiee MH, et al: Histological and biochemical alterations in earlystage lobar ischemia-reperfusion in rat liver. World J Gastroenterol 2009; 15: 1951-1957.
37. Beauchamp P, Richard V, Tamion F, et al: Protective effects of preconditioning in cultured rat endothelial cells: effects on neutrophil adhesion and expression of ICAM-1 after anoxia and reoxygenation. Circulation 1999;100:541-546.
38. Hafez T, Moussa M, Nesim I, et al: The effect of intraportal prostaglandin E 1 on adhesion molecule expression, inflammatory modulator function, and histology in canine hepatic ischemia/reperfusion injury. J Surg Res 2007;138:88-99.
39. Teoh NC, Ito Y, Field J, et al: Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemiareperfusion injury in mice. Gastroenterology 2007;133: 632-646.
40. Yuan GJ, Ma JC, Gong ZJ, et al: Modulation of liver oxidant-antioxidant system by ischemic preconditioning during ischemia/reperfusion injury in rats. World J Gastroenterol 2005;11: 1825-1828.
41. Sindram D, Rudiger HA, Upadhya AG, et al: Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanism. J Hepatol 2002;36:78-84.
42. Kannerup AS, Gronbaek H, Funch-Jensen P, et al: Cytokine changes during warm ischemia and reperfusion of the pig liver with or without preconditioning. Eur Surg Res 2009; 42: 216-222.
43. Li XC, Ma YF, Wang XH: Role of NF-kappaB as effector of IPC in donor livers before liver transplantation in rats. Transplant Proc 2006;38:1584-1587.
44. Fernandez L, Carrasco-Chaumel E, Serafin A, et al: Is ischemic preconditioning a useful strategy in steatotic liver transplantation? Am J Transplant 2004;4:888-899.
45. Teoh N, Leclercq I, Pena AD, et al: Low-dose TNF-alpha protects against hepatic ischemia- reperfusion injury in mice: implications for preconditioning. Hepatology 2003; 37:118-128.
46. Teoh N, Field J, Sutton J, et al: Dual role of tumor necrosis factor-alpha in hepatic ischemia- reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice. Hepatology 2004;39: 412-421.
47. Taub R: Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5: 836-847.
48. Selzner N, Selzner M, Odermatt B, et al: ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology 2003;124:692-700.